|DR prevalence of DR higher in T1s; T2s have the major burden….|
|One of the microvascular complications of type 1 and type 2 diabetes is diabetic retinopathy (DR), which can cause blindness and low vision in this patient population along with other age-related eyes condition. Many screening programs have been introduced and implemented worldwide to better detect, diagnose, and treat DR. The goal of this study was to determine the prevalence of DR using a large community based screening program in order to accurately estimate the future burden of this specific and debilitating complication of diabetes.A total of 220 locations throughout Wales were included in the community-based mobile screening service called National Diabetic Retinopathy Screening Service for Wales (DRSSW). Screening inclusion criteria included diabetic patients with age ≥ 12 years without any eye-related diseases. Exclusion criteria included patients <12 years old, those who were already under the care of hospital eye services (HES) for DR-related reasons, and those with medical reasons. For type 1 diabetes, age at diagnosis was divided into subgroups ≤12 yrs, 13–23 yrs and ≥24 yrs. Diabetes duration was also divided into subgroups <10 yrs, 10–19 yrs and ≥20 years. For type 2 diabetes, the subgroups for age at diagnosis were ≤55 yrs, 56–66 yrs and ≥67 yrs, and for diabetes duration were <5 years, 5–9 years and ≥10 years, respectively. Several tests such as t-tests and chi-squared tests with p value of <0.05 were used for statistical analyses. Logistic regression analyses were also performed to assess the association of variables to DR status.
From January 2015 to November 2009, a total of 91,393 patients including 5,003 type 1 diabetic patients and 86,390 type 2 diabetic patients were screened by DRSSW……..
Read more: http://www.diabetesincontrol.com/articles/diabetes-news/17826-risk-of-retinopathy-in-type-1-and-type-2-diabetic-patients
Source: Diabetes in Control